Pygeum for Benign prostatic hyperplasia

Evidence grade C — Modest

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

Outcome	Grade	Effect size	Agreement
Benign prostatic hyperplasiaModest	Evidence grade C	Unclear	mixed

Read off the same rows as above. Nothing here is added that the entry does not itself record.

For benign prostatic hyperplasia, Pygeum earns evidence grade C (unclear effect, mixed consistency) — the evidence is limited or mixed. Modest

Anti-inflammatory and anti-proliferative effects on prostate tissue.

100–200 mg standardized extract daily.

Generally safe; mild GI effects.

A modest, older-evidence prostate option, usually combined. Low-risk trial.

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Entries that share this one's tags or conditions.

Saw Palmetto for Benign prostatic hyperplasiaEvidence grade C — Trial 8–12 weeksEvidence grade C
Stinging Nettle for Benign prostatic hyperplasiaEvidence grade C — ModestEvidence grade C
Pygeum for BPH urinary symptomsEvidence grade C — Older dataEvidence grade C
Saw Palmetto for BPH urinary symptomsEvidence grade C — CAMUS nullEvidence grade C

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised Jul 10, 2026. A grade is this entry's reading of the evidence, not medical advice.